Efficacy of the Andresen activator before peak growth in class II patients.
Faccioni P, De Santis D, Luciano U, Pancera P, Sinigaglia S, Iurlaro A, Bertossi D, Lucchese A, Manuelli M, Maestrini S, Kumar N, Zotti F, Donadello D, Ricciardi G, Albanese M, Cicalese MP.